Business Inquiry
Global:
Email:marketing@medicilon.com
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
The non-clinical safety risks of cell therapy (such as CAR-T cells) mainly include:
1. Cytokine release syndrome (CRS)
2. Graft-versus-host disease (GVHD)
3. Reversible neurotoxicity
4. Reduction of B cells
5. On-target/off-tumor
6. Tumorigenicity/tumorigenicity